Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

LAB Standard BioTools Inc. Common Stock
$1.52 -2.56% -0.04
Notify me if price changes either direction
Interactive Brokers Logotype

Buy LAB stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 580.7M
Enterprise value 202.8M
Trailing PE -2.9038461355063
Forward PE -37.75
PEG Ratio -0.10163461474272
Enterprise to EBITDA -1.636
Enterprise to revenue 1.195
Price to book MRQ 1.2236629
Price to sales TTM 3.4211385

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 169.7M
EBITDA -123949000
Diluted EPS TTM -0.39
Total Cash (MRQ) 28.5M
Current ratio (MRQ) 4.376
Operating Cash Flow (TTM) -87212000

LAB trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent LAB News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.